Weekly Top Ten News Stories

Array
(
    [0] => Array
        (
        )

    [1] => Array
        (
        )

)

Weekly update on recommendation, target price, and earnings forecast changes.

Nick Linton-Ffrost of Fifth Wave suggests the 5150-5170 level in the ASX200 is technically significant on an upside basis.

Not bad as feared, conclude analysts post the February reporting season, but what exactly does it mean?

 In This Week's Weekly Insights: – The Bear Market Diaries – Episode 4 – Reporting Season – Before And After – WorleyParsons Rallies – ETFs & Shorts – Oil – When Everyone Sees Recovery – #NigelNoMates: Sticking Around – Rudi On Tour – Nothing Ever

Peter Switzer of the Switzer Super Report discusses whether 2016 will be another "Sell in May" story.

Anglo American's Queensland assets; equity outlook stemming from results season; Goldman Sachs' Small & Mid Cap Focus List; real estate classified trends.

FNArena's weekly update on short positions in the Australian share market.

Sirtex Medical's salvage therapy for metastatic colorectal cancer should sustain high compound growth and returns, Morgan Stanley contends.

Brokers welcome Orora's first major acquisition since its de-merger from Amcor, a specialist packaging business based in the US.

A wrap of the Australian corporate result season now concluded, including broker views, ratings and target price changes and beat/miss assessments.